Valiant Laboratories IPO GMP History
Valiant Laboratories IPO has been listed on October 6, 2023 at a listing price of ₹162.15, against the issue price of ₹140 — a gain of ₹22.15 (+15.82%). The GMP peaked at ₹25 on 5 October 2023 and reached a low of ₹0 on 27 September 2023. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Valiant Laboratories IPO raised ₹152.46 Cr. through its IPO at a price band of ₹133 to ₹140 per share, with a lot size of 105 shares. The IPO was open for subscription from 27 Sep 2023 to 03 Oct 2023.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 10 Nov, 6:13 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 05 Oct 2023 | ₹ 25 | ▲ | 18% | — | — |
| 04 Oct 2023 | ₹ 20 | ▲ | 14% | — | — |
| 03 Oct 2023 | ₹ 15 | — | 11% | — | — |
| 02 Oct 2023 | ₹ 15 | — | 11% | — | — |
| 30 Sep 2023 | ₹ 15 | ▲ | 11% | — | — |
| 29 Sep 2023 | ₹ 10 | ▲ | 7% | — | — |
| 28 Sep 2023 | ₹ 0.05 | ▲ | -- | — | — |
| 27 Sep 2023 | ₹ 0 | — | -- | — | — |
Valiant Laboratories IPO dates
Key dates from opening to listing. Today is 11 November.
- Open 27 Sep 2023
- Close 03 Oct 2023
- Allotment 05 Oct 2023
- Refund/credit 06 Oct 2023
- Listing 06 Oct 2023
Valiant Laboratories IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹140 |
|---|---|
| GMP-based estimate (pre-listing) | ₹165 (+17.9%) |
| Listing gain / loss | +₹22.15 per share |
| Listing date | 06 Oct, 2023 |
| Actual listing price | ₹162.15 (+15.82%) |
Is Valiant Laboratories IPO GMP reliable?
Grey market premium for Valiant Laboratories IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Valiant Laboratories IPO full review for a fundamentals-based assessment before making any grey market trades.
Valiant Laboratories IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Valiant Laboratories IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Valiant Laboratories IPO
Valiant Laboratories Limited is a pharmaceutical ingredient maker focused on paracetamol, a bulk drug used as raw material for finished dosage forms.
It operates out of a single manufacturing facility at Boisar, Palghar, Maharashtra, which also has an R&D facility with an analytical laboratory.
It imports para amino phenol, the key raw material for paracetamol, from China and Cambodia.
The IPO was Rs 152.46 crore and was entirely fresh issue. Rs 80.00 crore was planned for its subsidiary VASPL to set up a new facility and Rs 45.00 crore for VASPL's working capital.
Frequently asked
What is the GMP of Valiant Laboratories IPO?
The current Grey Market Premium (GMP) of Valiant Laboratories IPO is ₹ 25.
What is the Kostak Price of Valiant Laboratories IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Valiant Laboratories IPO is not available.
What is the Subject to Sauda Price of Valiant Laboratories IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Valiant Laboratories IPO?
Valiant Laboratories IPO listed on October 6, 2023 at ₹162.15, against the issue price of ₹140 — a gain of +15.82%.
How did the GMP of Valiant Laboratories IPO trend before listing?
The GMP of Valiant Laboratories IPO was rising in its final days before listing. The GMP peaked at ₹25 on 5 October 2023. View the day-wise table above for the complete GMP history.
Explore Valiant Laboratories IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
